ISRG vs MRK
ISRG: Intuitive Surgical designs and manufactures robotic-assisted surgical platforms that enable minimally invasive procedures with superior precision and clinician control. MRK: Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
Side-by-side fundamentals
| Metric | ISRG | MRK | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $411.55 | $125.07 | |
| Market cap as of 2026-07-10 | $145.7B | $310.1B | |
| P/E as of 2026-07-10 | 48.90 | 34.71 | MRK lower |
| PEG as of 2026-07-10 | 2.97 | 4.34 | ISRG lower |
| Net margin as of 2026-07-10 | +28.1% | +13.6% | ISRG higher |
| Gross margin as of 2026-07-10 | +66.3% | +78.1% | MRK higher |
| Operating margin as of 2026-07-10 | +30.4% | +18.2% | ISRG higher |
| ROE as of 2026-07-10 | +17.0% | +17.9% | MRK higher |
| ROA as of 2026-07-10 | +14.9% | +7.0% | ISRG higher |
| Debt / equity as of 2026-07-10 | 0.00 | 1.07 | ISRG lower |
| Revenue growth (YoY) as of 2026-07-10 | +21.4% | +2.9% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | +3.1% | ISRG higher |
| Dividend yield as of 2026-07-10 | n/a | +2.7% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-10 | 1.46 | 0.21 | |
| 1-year return as of 2026-07-09 close | -22.1% | +49.4% | MRK higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.